Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Micaela R. Scobie
Observed names:
Micaela R Scobie,
Micaela Scobie
Institutions:
United States Department of Veterans Affairs,
Veterans Health Administration
Observed institutions:
United States Department of Veterans Affairs,
Veterans Health Administration,
Durham VA Medical Center,
Clemson University
ORCID:
0000-0002-9217-0562
Observed ORCID:
0000-0002-9217-0562
OpenAlex ID:
A5077451306
Utility of Tumor Mutational Burden as a Biomarker for Response to Immune Checkpoint Inhibition in the VA Population
2023
·
Micaela R. Scobie
, Katherine I. Zhou
, et al.
·
JCO Precision Oncology
·
15
Modulation of glioma-inflammation crosstalk profiles in human glioblastoma cells by indirubin-3’-(2,3 dihydroxypropyl)-oximether (E804) and 7-bromoindirubin-3′-oxime (7BIO)
2019
·
Micaela R. Scobie
, Haley R. Houke
, et al.
·
Chemico-Biological Interactions
·
9
Differential Transcriptome Responses in Human THP-1 Macrophages Following Exposure to T98G and LN-18 Human Glioblastoma Secretions: A Simplified Bioinformatics Approach to Understanding Patient-Glioma-Specific Effects on Tumor-Associated Macrophages
2023
·
Micaela R. Scobie
, Abdullah Abood
, et al.
·
International Journal of Molecular Sciences
·
8
PDF
Tolerability and Outcomes of Bruton Tyrosine Kinase Inhibitors for Chronic Lymphocytic Leukemia in Patients with Severe Renal Dysfunction
2023
·
Chenyu Lin
, Clare E Anderson
, et al.
·
Blood
·
3
Real world efficacy and safety of ivosidenib in US veterans with IDH1 mutated cholangiocarcinoma.
2025
·
Katherine Ismei Zhou
, Robin Nanda Baidya
, et al.
·
Journal of Clinical Oncology
·
2
PDF
Social vulnerability by neighborhood of association correlates with CAR T referrals.
2025
·
Clare E. Anderson
, Micaela R. Scobie
, et al.
·
Journal of Clinical Oncology
·
2
Impact of Social Determinants of Health and Novel Therapies on the Outcomes of Relapsed and Refractory Diffuse Large B Cell Lymphoma
2023
·
Chenyu Lin
, Micaela R Scobie
, et al.
·
Blood
·
1
PDF
Interference of clonal hematopoiesis in cfDNA liquid biopsy testing and identification of actionable alterations in large diverse cohort of US veterans
2026
·
Luca F Valle
, Micaela Scobie
, et al.
·
The Oncologist
75854 Impact of Care Setting on Timeliness of Mohs Surgery for Veterans with Non-Melanoma Skin Cancer
2026
·
Kali Morrissette
, Sakshi Chopra
, et al.
·
Journal of the American Academy of Dermatology
Lambert-Eaton myasthenic syndrome in United States veterans with small cell lung carcinoma (SCLC).
2026
·
Samantha Rueckeis
, Micaela R. Scobie
, et al.
·
Journal of Clinical Oncology
Real-world practice patterns of IDH inhibitors and outcomes of on-label IDH inhibitor use for Acute Myeloid Leukemia in the United States
2025
·
Chenyu Lin
, Ashley Woods
, et al.
·
Blood
62539 Evaluating the Impact of Travel Distance on Melanoma Care for North Carolina Veterans: No Significant Differences between Rural and Urban Settings
2025
·
Kelly Owens
, Kali Morrissette
, et al.
·
Journal of the American Academy of Dermatology
Outcomes of germline expedited point of care (POC) genetic testing through telehealth in the Veterans Health Administration (VA).
2025
·
Akiko Chiba
, Andrea Stoddard
, et al.
·
Journal of Clinical Oncology
PDF
Outcomes of Bruton tyrosine kinase inhibitors for chronic lymphocytic leukaemia in US veterans with severe renal dysfunction
2024
·
Chenyu Lin
, Clare E. Anderson
, et al.
·
British Journal of Haematology
PDF
CLL-027 Tolerability and Outcomes of Oral Targeted Inhibitors for Chronic Lymphocytic Leukemia in Patients with Severe Renal Dysfunction
2024
·
Clare Anderson
, Chenyu Lin
, et al.
·
Clinical Lymphoma Myeloma & Leukemia
Tolerability and Outcomes of Oral Targeted Inhibitors for Chronic Lymphocytic Leukemia in Patients with Severe Renal Dysfunction
2024
·
Clare Anderson
, Chenyu Lin
, et al.
·
Clinical Lymphoma Myeloma & Leukemia
Characteristics and clinical outcomes of US veterans with advanced non–small cell lung cancer (NSCLC) by KRAS subtype: A National Veterans Health Administration analysis.
2024
·
Clare E. Anderson
, Micaela R Scobie
, et al.
·
Journal of Clinical Oncology
Utility of pharmacogenomic testing in predicting intolerance to BTK inhibitors.
2023
·
Fahmin Basher
, Micaela R Scobie
, et al.
·
Journal of Clinical Oncology
PDF
Utilization of Pharmacogenomics in Assessment of Tolerability and Efficacy of BTK Inhibitors
2022
·
Fahmin Basher
, Micaela R. Scobie
, et al.
·
Blood
Prolymphocytic Progression of Chronic Lymphocytic Leukemia in the Era of Novel Targeted Therapies: A Nationwide Veterans Affairs Retrospective Review
2022
·
Chenyu Lin
, Micaela R. Scobie
, et al.
·
Blood
The Effects of Indirubin Derivative E804 on Inflammatory Profiles in Glioblastoma Multiforme Cell Lines and Subsequent Crosstalk Effect on Tumor Associated THP-1 Macrophages
2019
·
Micaela R. Scobie
·
TigerPrints (Clemson University)
PDF
Dres-07. Modulation of Inflammation Profiles and Ahr Signaling in Human Glioblastoma Multiforme Cell Lines by Indirubin Derivatives E804 and 7bio
2017
·
Micaela R Scobie
, Charles D Rice
·
Neuro-Oncology
Show more works
View as search
Works count:
22
Citation count:
40
H-index:
3
I10-index:
1
Year
Topic
Type